Aims and Scope of Oncology Reports
Oncology Reports is a peer-reviewed medical journal of oncology published monthly by Spandidos Publications. The editor-in-chief is Demetrios A. Spandidos. The journal was established in 1994.
Key Metrics
CiteScore 

7.6
Eigenfactor 

0.01 - 0.05
H-Index 

108
Impact Factor 

< 5
SJR 

Q2Oncology

SNIP 

0.79
Recommended pre-submission checks
Powered by 

Topics Covered on Oncology Reports
Oncology Reports Journal Specifications
| Overview | |
| Publisher | SPANDIDOS PUBL LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Oncology Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Oncology Reports
Cancer signaling networks in tumor progression and drug resistance: Crosstalk, adaptive reprogramming and therapeutic targeting (Review).
- 1 Jul 2026
- Oncology reports
Combination of ivermectin and metformin promotes autophagy in MCF‑7 cells by inhibiting phosphorylation of the PI3K/AKT/mTOR pathway.
- 1 Jul 2026
- Oncology reports
SRRT promotes prostate cancer progression and serves as a prognostic biomarker through STAT3 pathway activation.
- 1 Jul 2026
- Oncology reports
Retracted] PTEN enhances G2/M arrest in etoposide‑treated MCF‑7 cells through activation of the ATM pathway.
- 1 Jul 2026
- Oncology reports
A novel regulatory role of microRNA‑5590‑3p in hepatocellular carcinoma via the HOXB2/MYC axis.
- 1 Jul 2026
- Oncology reports
Corrigendum] ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune micro-environment.
- 1 Jul 2026
- Oncology reports
Cancer signaling networks in tumor progression and drug resistance: Crosstalk, adaptive reprogramming and therapeutic targeting (Review).
- 1 Jul 2026
- Oncology reports
Combination of ivermectin and metformin promotes autophagy in MCF‑7 cells by inhibiting phosphorylation of the PI3K/AKT/mTOR pathway.
- 1 Jul 2026
- Oncology reports
SRRT promotes prostate cancer progression and serves as a prognostic biomarker through STAT3 pathway activation.
- 1 Jul 2026
- Oncology reports
Retracted] PTEN enhances G2/M arrest in etoposide‑treated MCF‑7 cells through activation of the ATM pathway.
- 1 Jul 2026
- Oncology reports
A novel regulatory role of microRNA‑5590‑3p in hepatocellular carcinoma via the HOXB2/MYC axis.
- 1 Jul 2026
- Oncology reports
Corrigendum] ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune micro-environment.
- 1 Jul 2026
- Oncology reports
FAQs on Oncology Reports
How long has Oncology Reports been actively publishing? 
What is the publishing frequency of Oncology Reports? 
How many articles did Oncology Reports publish last year? 
What is the eISSN & pISSN for Oncology Reports? 
What is Citescore for Oncology Reports? 
What is the H Index for Oncology Reports ? 
What is SNIP score for Oncology Reports? 
What is the SJR for Oncology Reports? 
Who is the publisher of Oncology Reports? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary